The Business of Digital Health in Africa: Who Actually Makes Money?

The Macroeconomic Illusion and the Revenue Conundrum

The digitalization of healthcare systems across the African continent has long been heralded as the ultimate mechanism to leapfrog structural deficits, overcome severe doctor-to-patient ratios, and deliver universal health coverage to historically underserved populations. Over the past two decades, the integration of information technology tools—spanning electronic health records (EHRs), telemedicine platforms, health monitoring devices, and artificial intelligence-driven diagnostic systems—has promised to reduce medical errors, enhance clinical workflows, and increase system-wide revenue by simplifying billing processes.1 Driven by this profound promise to optimize care pathways and democratize access, the African health technology sector witnessed an unprecedented influx of venture capital, reaching a historic valuation and investment peak in 2021.2 However, the subsequent years have revealed a stark, uncompromising disconnect between technological innovation and commercial viability.

Despite a surge in early-stage seed funding, a significant proportion of digital health startups in the region remain trapped in a perpetual cycle of pilot programs, entirely unable to convert initial capital injections into sustainable, scaled revenue streams.2 The primary driver of this revenue conundrum is the "post-seed gap." Comprehensive market analysis indicates that while early-stage capital is relatively accessible for developing prototype software solutions and demonstrating localized proof-of-concept, follow-on venture capital fundamentally requires proof of positive unit economics, aggressive month-over-month revenue growth, and highly scalable distribution channels.2 In the African context, achieving these financial metrics is exceptionally difficult due to a confluence of severe non-financial frictions. These constraints include deeply entrenched regulatory hurdles across fragmented national jurisdictions, severe infrastructural deficiencies affecting broadband and electricity, astronomical talent acquisition costs for specialized software engineers, and profound market trust barriers among both patients and clinical providers.2 Mere capital infusion cannot overcome these systemic health-sector limitations. Consequently, very few digital health startups successfully transition from the seed stage to scaled commercial impact, a dynamic illustrated by the post-pandemic collapse of highly funded entities like Nigeria’s 54gene and the quiet closure of once-promising telemedicine platforms.2

Venture capital allocation to the health technology sector has contracted sharply in response to these realization of these structural barriers. By the first half of 2024, healthtech companies captured a mere five percent of the $1.2 billion in venture capital funding directed toward African startups, down from six percent in the previous year and significantly lower than the historical average of eight percent recorded between 2020 and 2023.4 Concurrently, international aid funding and development finance—traditionally a vital lifeline for healthcare innovators and early-stage social enterprises on the continent—have faced massive reductions, with projections from the Organisation for Economic Co-operation and Development (OECD) indicating declines of up to seventeen percent.4 This dual contraction of equity and aid capital has forced once-promising firms into aggressive survival modes, triggering sector-wide restructuring, mass layoffs, and outright shutdowns.

The closure of Antara Health’s operations in Kenya serves as a highly visible manifestation of this revenue crisis. Having built a strong reputation for delivering telemedicine services and virtual primary healthcare, Antara Health was working intimately with private insurers to manage the healthcare of policyholders through virtual consulting services and health risk management algorithms.4 Despite the conceptual brilliance of the model, the firm quietly laid off its entire staff and ceased operations in September 2024.4 Company representatives noted that the decision to close down operations was driven by the reality that growth was exceedingly slow, and institutional investors chose not to inject further capital into a highly illiquid operational model.4 Unlike financial technology (fintech) platforms that benefit from rapid transaction velocity and immediate network effects, healthtech depends heavily on forging complex, slow-moving partnerships with hospitals, pharmacies, and government institutions.4

The Structural Anatomy of Digital Health Revenue Failures

To understand why monetization is so elusive in African digital health, one must analyze the socio-technical realities of healthcare delivery in low-resource settings. Digital interfaces cannot function in a vacuum; they rely entirely on the physical infrastructure and human capital of the health system they attempt to augment. When the digital architecture outpaces the physical reality, the perceived value of the software collapses, taking the startup's revenue model down with it.

This dependency is acutely visible in the deployment of Kenya’s ambitious electronic Community Health Information System (eCHIS). Designed to transform healthcare delivery and drive Universal Health Coverage, the eCHIS was built to equip 95,000 Community Health Promoters (CHPs) with state-of-the-art digital tools.5 Co-created by the Ministry of Health, Medic, and Living Goods, and built upon the open-source Community Health Toolkit (CHT), the platform theoretically facilitates near real-time data collection, commodity management, and disease surveillance.6 While the top-down metrics suggest massive scale and national success, the frontline reality is fraught with systemic friction. Across informal settlements like Mukuru Kwa Njenga in Nairobi and rural counties like Nyamira, CHPs report frozen mobile hardware, unreliable server connectivity, inadequate financial stipends, and weak technical support structures.5 These infrastructural failures frequently force health workers to abandon the multibillion-shilling digital overhaul and revert to manual notebooks and paper reconciliations.5

The human cost and systemic breakdown of this digital-physical collision is profound. In one documented scenario in Nairobi, a Community Health Promoter utilized the digital system to refer a critically ill patient to Mama Lucy Kibaki Hospital.5 Despite the digital referral being processed and transmitted, the data carried no operational weight at the congested public referral facility. The patient was forced into standard manual triage queues, bypassed by the overwhelmed clinical staff, given basic medication, and sent home, where he subsequently died two days later.5 The tragedy encapsulates everything broken about the chain of care: from frozen mobile applications and delayed data submission to physical hospital queues that ignore digital triage protocols.5 If the end-user—whether a patient seeking care, a doctor seeking diagnostic clarity, or a government administrator seeking epidemiological data—cannot derive immediate, tangible, and life-saving value from the software, monetization becomes an absolute impossibility. The software becomes a burden rather than an enabler.

Furthermore, the business of healthcare requires navigating highly fragmented and frequently adversarial incentive structures. Dr. Joshua Kibera, the CEO and Founder of The Pathology Network (TPN) in Kenya, articulates this structural challenge perfectly: to make a successful sale in the digital health space, a startup must convince a multitude of stakeholders simultaneously.9 A vendor must successfully navigate doctors who prioritize clinical efficacy and workflow integration, hospital administrators whose sole focus is cost reduction and margin expansion, regulators who demand strict compliance and data sovereignty, and ultimately patients who require extreme affordability.9 Because these parties are motivated by vastly different—and often conflicting—incentives, the enterprise sales cycle for digital health products is notoriously long and complex, frequently draining a startup's financial runway long before any meaningful, recurring revenue can be realized.9

Decoding Sustainable Business Models in African Healthtech

As pure-play direct-to-consumer (B2C) applications falter under the weight of low consumer purchasing power, high customer acquisition costs, and minimal willingness to pay out-of-pocket for digital diagnostics, the ecosystem has undergone a strategic realignment. The entities that are actually generating sustainable revenue and achieving profitability in African digital health are those operating robust Business-to-Business (B2B), Business-to-Government (B2G), and employer-led capitation models.

The B2B Healthcare Sales Playbook and Trust Mechanics

The Business-to-Business (B2B) model in African healthcare requires an acknowledgment that software sales are inherently relationship-driven. Procurement decisions in local hospitals, diagnostic centers, and private clinic networks rely heavily on personal trust, localized context, and risk mitigation, rather than purely on Western-style contractual efficiency or generic software demonstrations.10 Consequently, B2B sales in the region must be intimately founder-led. Founders are required to lead early pilots because they uniquely possess the authority to adapt product strategy in real-time, articulate a long-term commercial vision, and transcend the bureaucratic resistance frequently encountered in mid-tier African hospitals.10

Scaling innovation through structured B2B pilot programs is governed by a rigorous 10-step playbook tailored for the African market.10 This framework operates on the reality that pilots must be treated as trust-building, risk-mitigation, and value-demonstration mechanisms rather than mere product tests.10 A successful B2B pilot requires the establishment of three distinct pillars of trust during the procurement cycle: competence trust (the absolute belief that the technical solution actually works), relational trust (the belief that the startup team is reliable and responsive), and contextual trust (the belief that the software engineering team deeply understands the local infrastructural, regulatory, and cultural environment).10

The structural realities shaping this playbook include extreme cost sensitivity, meaning pilots must demonstrate near-term Return on Investment (ROI) to secure constrained hospital budgets.10 Furthermore, the fragmented nature of legacy paper-based workflows requires customized data flow mapping and co-designing workflow integration directly with clinical staff.10 To successfully convert a pilot into a long-term enterprise contract, startups must present exhaustive evidence generation, including quantitative performance data, patient outcomes, efficiency reports, and cost-benefit analyses.10 Conversion-focused pilots rely heavily on ROI calculators, tiered pricing models adapted for local purchasing power, and outcome-linked contracts that share the financial risk between the startup and the healthcare facility.10

A compelling, highly successful example of B2B monetization is The Pathology Network (TPN) in Kenya. TPN operates a decentralized, AI-powered diagnostic platform that connects rural and urban hospitals to a specialized, distributed network of global and local pathologists.9 Recognizing that most mid-tier hospitals across Africa cannot afford to employ full-time specialized anatomical pathologists, TPN uses a B2B membership-like model to recruit medical facilities into its network.12 The platform handles the entire diagnostic lifecycle: physical sample logistics, laboratory selection, rigorous quality oversight, and the digital transmission of diagnostic results via an integrated software suite that includes mobile applications for doctors and pathologists.11

By removing the massive capital expenditure of building in-house pathology departments for hospitals, and simultaneously providing independent pathologists with a steady, aggregated stream of diagnostic requests, TPN perfectly aligns the fragmented incentives of administrators and clinicians.9 Powered by artificial intelligence that integrates into early screening for diseases such as cancer, TPN serves over 40 medical facilities and 100 doctors across Kenya.11 TPN is not only generating sustainable revenue but has established viable unit economics that support ambitious expansion plans across 10 African countries over the next decade.11 This proves that B2B platforms solving immediate, highly technical clinical bottlenecks can bypass the monetization struggles faced by generalized consumer-facing applications.

The Illusions of Pure B2C and the Shift to Hybrid Models

While pure B2C digital health applications—such as virtual symptom checkers and standalone telemedicine apps—struggle to monetize due to the reluctance of consumers to pay for virtual advice without physical treatment, hybrid models that blend digital convenience with physical fulfillment are thriving. In the pharmaceutical distribution sector, the evolution of MyDawa serves as a blueprint for consumer monetization in East Africa.

Founded in Kenya in 2017, MyDawa has evolved from a pure digital pharmacy into a deeply integrated "bricks-and-clicks" hybrid platform.14 Supported by a massive $9.6 million funding round from a consortium of global investors—including private equity firms Alta Semper and Creadev, the Danish government-affiliated Investment Fund for Developing Countries (IFU), Japan's AAIC Investment, and Ohara Pharmaceutical Co.—MyDawa integrates physical distribution networks with advanced e-pharmacy services.14

The platform allows patients to consult doctors online, order laboratory tests, receive electronic prescriptions, and have medications delivered directly to their homes.15 This is a critical service in regions where physical pharmacies are scarce, stockouts are rampant, and the proliferation of counterfeit medication is a constant threat.15 Recognizing that scale requires controlling the entire patient journey, MyDawa executed a strategic regional consolidation by acquiring Uganda’s leading telehealth provider, Rocket Health.15 This acquisition allowed MyDawa to instantly acquire cross-border market share, integrate advanced telehealth capabilities, and expand its patient base to over 1.8 million users without engaging in costly organic customer acquisition campaigns in a new territory.15

By leveraging AI technology to optimize pharmaceutical inventory management, streamline service provision, and reduce logistical costs, MyDawa reported over 30 percent year-over-year revenue growth in 2024.14 The firm plans to utilize its new capital to open 30 physical stores in Uganda and 10 in Kenya, aiming to serve more than 8 million patients annually by 2032.14 MyDawa's trajectory proves conclusively that blending physical infrastructure with digital access is a prerequisite for achieving profitable B2C scale in the African context.

Sovereign Financing and the New B2G Reality

The public sector remains the absolute largest provider of healthcare services across the African continent, making Business-to-Government (B2G) models highly lucrative, albeit exceptionally slow and politically complex to penetrate. Navigating B2G procurement requires startups to intimately align their software solutions with national policy objectives, such as the pursuit of Universal Health Coverage (UHC), and to integrate seamlessly with legacy public health infrastructure.16

A prominent strategy for B2G commercialization is the Public-Private Partnership (PPP). A landmark example of this macro-financial architecture is the Managed Equipment Services (MES) partnership executed between the Kenyan Ministry of Health and GE Healthcare.17 Designed to decentralize specialized healthcare services from national referral centers down to the county level, the MES allows the Kenyan government to adopt a 'pay for service' expenditure plan.17 This model defers the massive upfront capital outlays traditionally required for radiological equipment, allowing the Ministry of Health to budget healthcare expenditure over a manageable seven-year period.17 This financial architecture enabled the modernization of 98 hospitals across 47 counties, increasing access to digital mammography and teleradiology, while simultaneously providing the corporate vendor with a highly reliable, multi-year sovereign revenue stream.17 The success of this model has seen a 50 percent improvement in access to radiology services across pilot hospitals and allowed in-house mammography exams for the first time in numerous level 5 hospitals.17

Furthermore, the macro-financial landscape of B2G healthcare is currently undergoing a paradigm shift that will dramatically alter how digital health companies secure public revenue. In December 2025, the United States and Kenya officially signed the "America First Global Health Strategy," a historic five-year, $1.6 billion bilateral cooperation framework.18 This agreement marks a profound departure from decades of traditional global health development finance. Instead of channeling billions of dollars through international Non-Governmental Organizations (NGOs)—which previously consumed significant percentages of capital in administrative overhead and imposed parallel health systems—the new strategy mandates a direct co-investment model.18

Under this framework, funding flows directly from the U.S. government to Kenyan state institutions, with the Kenyan government contributing an additional $850 million to the initiative.18 Designed explicitly to reduce donor dependency, cut administrative waste, and build robust state capacity, the pact requires Kenya to absorb thousands of health workers and progressively assume full financial responsibility for its health programs by the year 2030.21 For digital health startups, this geopolitical shift is highly consequential. It systematically diminishes the purchasing power of international NGOs, which have historically served as the primary B2B clients and grant providers for healthtech pilots across the continent.19 Consequently, procurement power is now hyper-centralized within the Ministry of Health and bodies such as the Social Health Authority (SHA).21 Startups must urgently pivot their go-to-market strategies, optimizing their solutions to win direct sovereign tenders and integrate into national digital health superhighways rather than relying on fragmented, short-term NGO grants.22

Employer-Led Benefits and the Capitation Imperative

Given the stubbornly low penetration of individual consumer health insurance across the continent, innovative healthcare companies are shifting aggressively toward employer-led benefits and capitation models to secure guaranteed, recurring revenue. In a capitation model, healthcare providers are paid a set, pre-arranged amount per patient over a specific period, regardless of how many services the patient ultimately utilizes.24 This fundamentally shifts the financial incentive structure away from the traditional Fee-For-Service (FFS) model—which inherently incentivizes a high volume of treatments and diagnostic tests to maximize billing—toward preventive, high-value care that minimizes long-term operational costs.24

Penda Health, a major primary care provider in Kenya, is actively transitioning its revenue architecture entirely toward this capitation model.25 By partnering directly with employers and institutional payers to offer unlimited outpatient coverage for a flat annual fee, Penda Health assumes the financial risk of patient care but guarantees highly predictable cash flow.25 This economic dynamic forces extreme internal operational efficiency, strict quality control, and a massive reliance on digital triage tools to maintain profitability and prioritize clinical outcomes over the sheer volume of services provided.25

Similarly, TIBU Health has effectively bypassed the sluggish and price-sensitive consumer market by pivoting heavily to an omnichannel corporate wellness model.26 Operating across physical wellness hubs, at-home mobile dispatch teams, and virtual telemedicine consultations, TIBU generates its core revenue by selling annual B2B health memberships directly to Small and Medium Enterprises (SMEs).26 Priced at approximately $100 per person annually, these memberships offer employees unlimited access to outpatient clinical services, drastically undercutting traditional private health insurance premiums that routinely range from $600 to $1,000 per person.26

The financial performance of this employer-led model is exceptional. With over 150 corporate clients—including major entities such as Knight Frank, the United Nations, the World Bank, and NCBA—and having processed over 45,000 patients and 20,000 diagnostic investigations, TIBU Health has achieved break-even status multiple times.26 Reporting over 200 percent year-over-year growth, the company has generated over $1.4 million in revenue since its launch.26 TIBU’s trajectory, supported by investments from Toyota Ventures (CFAO), Boost VC, and Netcare, highlights a vital truth: targeting the stable balance sheets of corporate employers, rather than the sparse out-of-pocket wallets of individual citizens, is one of the most viable and highly lucrative paths to healthtech profitability in Africa.26

The High Profitability of "Unsexy" Infrastructural Niches

While venture capital historically gravitated toward glamorous consumer-facing applications, symptom checkers, and glossy telemedicine platforms, the actual monetization within African healthtech is overwhelmingly concentrated in the "picks and shovels" of the industry. The most profitable entities are those building the unsexy, invisible infrastructural layers of healthcare: revenue cycle management, insurance claims adjudication, and physical supply chain logistics.30

Revenue Cycle Management (RCM), Billing, and Claims Adjudication

The administrative burden of healthcare in Africa is a massive, systemic drain on capital. Manual paper-based claims, rampant billing fraud, opaque pricing, and agonizingly slow reimbursement cycles suffocate hospital cash flows and artificially inflate insurance premiums for the end consumer. Startups that digitize and automate these financial workflows are highly profitable because their value proposition to institutional clients is immediate, mathematically quantifiable cost reduction.

Curacel, a B2B insurtech infrastructure platform operating across Nigeria, Kenya, Ghana, Uganda, and Egypt, perfectly exemplifies the immense profitability of infrastructural software.31 Founded in 2019, Curacel utilizes advanced Artificial Intelligence (AI) and Machine Learning (ML) to automate claims adjudication, conduct risk assessments, and execute real-time fraud detection.31 In African markets where severe data gaps have historically impaired underwriting accuracy and enabled rampant fraud, Curacel's "Extract AI" module instantly converts unstructured, paper-based claim documents into structured digital data.32 This data is subsequently run against vast algorithmic rule engines to detect anomalies and verify policy parameters without human intervention.33

The impact on operational efficiency for insurers and Health Maintenance Organizations (HMOs) is profound. Partnering facilities report processing up to four times their usual daily claim volume.33 By accurately identifying and curbing fraudulent submissions, Curacel saves insurers up to 20 percent in lost revenue, fundamentally protecting the financial security of the underwriter.33 Furthermore, Curacel actively monetizes through its "Curacel Grow" API, an embedded finance solution that allows logistics firms, fintechs, and e-commerce platforms to cross-sell insurance products at the point of checkout.31 This API generates commission-based revenue while drastically expanding insurance distribution channels into informal and rural sectors that traditional brokers cannot reach.31

In Kenya, the M-TIBA platform has revolutionized health financing by creating a dedicated mobile health wallet linked to the ubiquitous M-PESA telecommunications network.35 Developed through a powerful consortium comprising CarePay, Safaricom, and the PharmAccess Foundation, M-TIBA enables individuals to save funds, receive targeted donor subsidies, and pay for medical expenses securely.16 Crucially, the platform ensures that funds are ring-fenced strictly for healthcare expenditures at over 5,000 empaneled facilities, preventing the diversion of medical savings toward non-essential consumer goods.16

Beyond the consumer wallet, M-TIBA serves as a robust digital administration engine for health insurers, capturing the lucrative B2B billing market.37 By automating the entire patient journey—from digital enrollment and point-of-care biometric identification to instant pre-authorization and claims processing—the platform has achieved staggering efficiency gains.37 Pre-authorization requests that historically took an average of three days in Kenya are now processed in near real-time.37 Claims settlement times have plummeted from a devastating 77 days to a mere 3 days, providing vital liquidity to hospitals.37 Most impressively, the M-TIBA architecture has slashed the annual administrative cost per insured member from $29 down to $1.37 By charging transaction fees and SaaS licensing to institutional payers, M-TIBA generates highly predictable, scalable revenue while actively serving over 4 million registered users.16

Medbook Kenya has pursued a similar infrastructural strategy by developing an end-to-end digital ecosystem encompassing Electronic Medical Records (EMR), practice management, and specialized billing software.40 Its Medihealth and Mediclaim products specifically target the severe revenue cycle bottlenecks present in Kenyan hospitals.41 By automating the application of highly complex billing rules imposed by the National Health Insurance Fund (NHIF) and private underwriters, Medbook ensures that clinical data matches financial claims prior to submission.41 This pre-submission validation drastically reduces the rejection rate of hospital invoices, directly improving facility liquidity and embedding Medbook as a mission-critical utility that medical facilities simply cannot afford to churn.41

Logistics, Supply Chain Optimization, and "Prudent Multiplicity"

The distribution of physical medical commodities—spanning essential pharmaceuticals, clinical consumables, and diagnostic hardware—is historically fraught with inefficiencies, lethal stockouts, and the unchecked proliferation of counterfeit medications. Startups digitizing the health supply chain capture massive transaction volumes, operating at the highly profitable intersection of e-commerce, warehousing, and clinical procurement.

A fundamental shift in supply chain theory across the African continent is the strategic move toward "prudent multiplicity." Exhaustive research indicates that attempting to ensure health commodity security through monopolistic public-sector logistics agencies often results in systemic failure.42 Without competitive market pressure, these state monopolies fundamentally lack the incentives to optimize delivery routing, reduce operational costs, or innovate against catastrophic supply disruptions.42 Instead, a state of prudent multiplicity—an economic arrangement where at least two full-line national logistics institutions compete rigorously to serve both government and private medical facilities—creates vital systemic resilience and pricing efficiency.42 This theoretical framework justifies the aggressive expansion and venture funding of private B2B digital marketplaces and pharmaceutical distribution networks across the continent.

Kasha, a rapidly scaling e-commerce and logistics platform focused initially on health, hygiene, and self-care products, perfectly demonstrates the explosive revenue potential of this sector. Founded in Rwanda by former Microsoft engineer Joanna Bichsel, and operating heavily in Kenya, Kasha targets the uniquely underserved demographic of low-income women in rural and semi-urban communities.43 Initially conceived to provide discreet, reliable access to contraceptives, HIV tests, and menstrual hygiene products, Kasha quickly evolved into a massive digital distribution channel for fast-moving consumer goods (FMCG) and pharmaceutical giants like Unilever and Johnson & Johnson.43

By rigorously controlling the last-mile delivery infrastructure and leveraging East Africa's high mobile internet penetration, Kasha acts as an indispensable B2B2C conduit, bypassing inefficient legacy wholesalers.45 The financial results validate the power of tech-enabled logistics: Kasha’s revenue surged exponentially from $1 million in 2020 to $50 million by the end of 2023.43 This financial dominance has funded aggressive geographic expansion into South Africa, the Democratic Republic of Congo, Burundi, Tanzania, Uganda, and West Africa.43

The sheer scale of the supply chain opportunity has also prompted unprecedented pan-African institutional action. The Africa Centres for Disease Control and Prevention (Africa CDC), in strategic partnership with UNICEF, is actively deploying a continental digital dashboard to map and track the end-to-end supply chain of essential medicines, outbreak response commodities, and nutritional supplies.46 Covering all 55 African Union Member States, this initiative aims to replace fragmented Excel spreadsheets with real-time, actionable insights.46 For digital health startups operating in logistics and inventory management, this integration of macro-level sovereign planning with micro-level physical distribution creates a highly lucrative environment for software integration, API licensing, and outsourced last-mile delivery contracts.46

Beyond Vanity Metrics: Valuations and Performance Indicators

The maturation of the African healthtech ecosystem has precipitated a severe correction in how companies are evaluated by private equity firms and venture capital markets. Historically, startups relied heavily on easily manipulated "vanity metrics"—such as gross app downloads, cumulative page views, total social media impressions, and unverified registered user counts—to project momentum and secure early-stage capital.47 However, these metrics frequently mask fundamental, terminal weaknesses in product-market fit, commercial viability, and clinical utility.48 A telemedicine application boasting 10 million Monthly Active Users (MAUs) holds zero strategic relevance if only a microscopic fraction of those users ever convert into paying customers, or if the platform fails to retain them over consecutive billing cycles.48

In the contemporary funding environment leading into 2026, capital allocators demand rigorous unit economics and performance indicators that directly impact the balance sheet.47 The table below outlines the critical differentiation between the vanity distractions of the past and the fundamental economic metrics driving healthtech valuations today.

Beyond standard financial arithmetic, healthtech valuations in Africa are increasingly governed by a nuanced "Beyond EBITDA" paradigm.50 While Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) remains the definitive benchmark for private equity buyouts in mature markets—with global healthcare multiples in 2025 ranging between 8x and 15x depending on intellectual property (IP) defensibility—early-stage valuation logic in Africa differs significantly from sectors like fintech.50

In African healthtech, a startup generating negative EBIT but possessing robust clinical validation, exclusive regulatory approvals, or profound health data network effects will frequently command a higher valuation premium than a marginally profitable firm lacking defensive moats.50 Investors critically evaluate the "cost-to-impact ratio," acknowledging that digital platforms deeply embedded into clinical workflows or national infrastructure (such as those managing chronic disease pathways or national pharmaceutical logistics) possess immense strategic exit value.50 Strategic acquisitions by global pharmaceutical distributors, legacy hospital networks, and telecommunications giants represent a far more viable liquidity event for these assets than conventional Initial Public Offerings (IPOs) on local exchanges.50

Qualitative user metrics also maintain strict numerical thresholds. Tools like the Net Promoter Score (NPS), which measures user willingness to recommend the service, must generally exceed zero to indicate basic viability, with scores above 50 considered excellent indicators of strong product-market fit.49 Furthermore, leading investors utilize the "Sean Ellis Test"—which bluntly asks active users how disappointed they would be if they could no longer use the product. The standard demands that more than 40 percent of users report they would be "very disappointed," confirming mathematically that the application has successfully transitioned from a digital novelty to an essential, irreplaceable utility.49

Market Corrections, Layoffs, and Strategic Consolidation

The years 2024 and 2025 represented a profound structural correction in the African technology landscape, characterized by the absolute termination of the "growth-at-all-costs" era. As global macroeconomic conditions shifted, interest rates altered capital flows, and risk appetites normalized, digital health companies were forced into an abrupt, aggressive pursuit of profitability.52

This macroeconomic reality manifested in a severe wave of strategic workforce reductions. In 2025, the African tech ecosystem recorded an estimated 2,421 layoffs, representing the highest annual total tracked in half a decade.52 Crucially, these reductions were not inherently indicative of sector collapse; rather, they represented calculated, deliberate corporate pivots designed to extend cash runways, eliminate non-core divisions, and rapidly accelerate the path to breakeven.52 For instance, Twiga Foods—a major player in B2B supply chain and distribution in Kenya—executed a massive corporate realignment, laying off over 300 employees as it transitioned away from capital-intensive direct logistics toward a highly streamlined, asset-light holding company model.52 Similarly, Equity Group in Kenya conducted sweeping dismissals of over 1,200 staff following the discovery of multi-million dollar internal fraud networks, underscoring that strict institutional governance, risk control, and operational integrity are now paramount mandates from both management and international shareholders.52

In stark contrast to the contraction in headcount and operational bloat, specialized healthcare private equity and late-stage capital deployment experienced a remarkable, highly concentrated resurgence. Global private equity investment in healthcare technology hit a multi-year high in 2025, escalating to $14.6 billion—a near 600 percent increase from the preceding year.53 In Africa, while the total volume of individual venture transactions decreased, the absolute volume of capital deployed increased consecutively across 2023, 2024, and 2025, totaling an impressive $544 million in the latter year.51

This statistical divergence confirms a vital macroeconomic trend: investors are no longer scattering small amounts of seed capital across hundreds of unproven, highly speculative ideas. Instead, they are aggressively concentrating vast sums of capital into a select few high-quality, mature assets capable of dominating regional markets.51 Healthtech captured approximately 11 percent of the total African startup funding rebound, demonstrating remarkable consistency and resilience compared to the volatile boom-and-bust cycles observed in other verticals like cryptocurrency and consumer fintech.54 The resilience of healthcare funding is directly attributed to its clear value propositions, the high revenue visibility afforded by B2B institutional contracts, and highly established regulatory frameworks.54

This immense concentration of capital is actively driving a wave of strategic Mergers and Acquisitions (M&A) and cross-border regional consolidation. As the market matures, fragmented startups offering single-point solutions are either being absorbed by or driven into obsolescence by heavily capitalized, deeply integrated platforms. MyDawa’s strategic acquisition of Uganda’s Rocket Health is the archetype of this consolidation strategy, allowing the Kenyan firm to instantly acquire cross-border market share, integrate telehealth capabilities, and expand its patient base to 1.8 million without engaging in costly organic customer acquisition campaigns in a new regulatory territory.15

The empirical evidence derived from the African digital health ecosystem clearly delineates who actually makes money. Profitability is largely absent in pure direct-to-consumer applications that rely on out-of-pocket payments from low-income demographics. Conversely, sustainable, compounding revenue is being generated by enterprises that operate as indispensable infrastructural utilities for institutional clients. The primary beneficiaries of the healthtech economy are B2B software providers automating revenue cycle management, platforms facilitating the secure administration of health financing, and tech-enabled logistics firms optimizing physical supply chains. As the sector navigates shifting sovereign funding landscapes, the defining metric of success will be an enterprise's ability to embed itself seamlessly into existing clinical workflows and national payment architectures, prioritizing stringent unit economics over vanity growth.

Works cited

1. Technical and regulatory challenges of digital health implementation in developing countries - Taylor & Francis Online, accessed February 12, 2026, https://www.tandfonline.com/doi/full/10.1080/13696998.2023.2249757

2. Beyond seed funding: why Nigerian digital health startups struggle to grow - PMC, accessed February 12, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12797844/

3. Digital Health Trends 2025 | IQVIA, accessed February 12, 2026, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/digital-health-trends-2025

4. Kenya: Healthtech start-ups ailing from funding crunch - ZAWYA, accessed February 12, 2026, https://www.zawya.com/en/economy/africa/kenya-healthtech-start-ups-ailing-from-funding-crunch-ha8gy4q6

5. Broken system: How Kenya's digital health revolution is failing on the frontline | Daily Nation, accessed February 12, 2026, https://nation.africa/kenya/health/broken-system-how-kenya-s-digital-health-revolution-is-failing-on-the-frontline-5291546

6. Kenya's eCHIS to Be Scaled Nationwide After Successful Pilot - Living Goods, accessed February 12, 2026, https://livinggoods.org/media/after-a-successful-pilot-kenya-echis-to-be-scaled-countrywide/

7. Medic Partners with Kenyan Government to Transform Community Health, accessed February 12, 2026, https://medic.org/stories/medic-partners-with-kenyan-government-to-transform-community-health/

8. AI and Health Apps: Revolutionising Healthcare on mobile platforms (eCHIS) - YouTube, accessed February 12, 2026, https://www.youtube.com/watch?v=B288umZAuvo

9. From Obstacles to Opportunities: How Health Startups are ..., accessed February 12, 2026, https://villgroafrica.org/from-obstacles-to-opportunities/

10. Designing Pilots That Convert: The African Founder-Led B2B ..., accessed February 12, 2026, https://medstartups.org/founder-led-b2b-healthcare-sales-africa-pilot-design-playbook

11. THE PATHOLOGY NETWORK - HealthTech Hub Africa, accessed February 12, 2026, https://thehealthtech.org/company/the-pathology-network/

12. News - Villgro Africa, accessed February 12, 2026, https://villgroafrica.org/category/news/

13. Backing African healthcare startups: Insights from Kenya-based investor, accessed February 12, 2026, https://www.howwemadeitinafrica.com/backing-african-healthcare-startups-insights-from-kenya-based-investor/166125/

14. Raises US $9.6 Million to Expand "bricks-and-clicks" Pharmacy Model in East Africa, accessed February 12, 2026, https://aaicinvestment.com/mydawa_expand_20250619/

15. Kenya's MyDawa Scores Major Funding to Scale Its Bricks-and ..., accessed February 12, 2026, https://launchbaseafrica.com/2025/04/30/kenyas-mydawa-scores-major-funding-to-scale-its-bricks-and-clicks-healthtech-model-across-east-africa/

16. M-TIBA DIGITAL HEALTH PLATFORM CASE BRIEF - International Labour Organization, accessed February 12, 2026, https://www.ilo.org/sites/default/files/wcmsp5/groups/public/@ed_emp/documents/publication/wcms_749427.pdf

17. Transforming Kenya's healthcare system: a PPP success story - World Bank Blogs, accessed February 12, 2026, https://blogs.worldbank.org/en/ppps/transforming-kenya-s-healthcare-system-ppp-success-story

18. America First Global Health Strategy Investing in Kenyan Health - The Borgen Project, accessed February 12, 2026, https://borgenproject.org/america-first-global-health-strategy/

19. Secretary of State Marco Rubio with Kenyan President William Ruto at the Signing of a Health Framework of Cooperation, accessed February 12, 2026, https://www.state.gov/releases/office-of-the-spokesperson/2025/12/secretary-of-state-marco-rubio-with-kenyan-president-william-ruto-at-the-signing-of-a-health-framework-of-cooperation

20. WATCH: Rubio and Kenyan President Ruto speak after signing 'America First' global health deal - PBS, accessed February 12, 2026, https://www.pbs.org/newshour/world/watch-rubio-and-kenyan-president-ruto-speak-after-signing-america-first-global-health-deal

21. What the new Kenya–USA deal means for healthcare - Willow Health Media, accessed February 12, 2026, https://willowhealthmedia.org/what-the-new-kenya-usa-deal-means-for-healthcare/

22. Kenya, WHO Strengthen Strategic Partnership to Accelerate Universal Health Coverage, accessed February 12, 2026, https://www.health.go.ke/kenya-who-strengthen-strategic-partnership-accelerate-universal-health-coverage

23. United States and Kenya Sign Five-Year, $2.5 Billion Health Cooperation Framework, accessed February 12, 2026, https://www.state.gov/united-states-and-kenya-sign-five-year-2-5-billion-health-cooperation-framework

24. An Overview of Revenue Management Models in Healthcare, accessed February 12, 2026, https://www.doctorsmanagement.com/blog/an-overview-of-revenue-management-models-in-healthcare/

25. News Articles about Penda Health Limited, accessed February 12, 2026, https://www.pendahealth.com/articles

26. TIBU Health — Republic, accessed February 12, 2026, https://republic.com/tibu-2023

27. TIBU HEALTH CLOSES A PRE-SERIES A LED BY HEALTH54 TO ACCELERATE ITS GROWTH - CFAO, accessed February 12, 2026, https://www.cfaogroup.com/en/tibu-health-closes-a-pre-series-a-led-by-health54-to-accelerate-its-growth/

28. TIBU Health - Republic, accessed February 12, 2026, https://republic.com/tibuhealth

29. TIBU Health - Republic - Lustro - CrowdLustro, accessed February 12, 2026, https://crowdlustro.com/search/10159-TIBU-Health-on-Republic-Crowdfunding

30. Arab-Health-2025-Daily-Dose-Day-1_250127.pdf, accessed February 12, 2026, https://ssmc.ae/assets/uploads/2025/02/Arab-Health-2025-Daily-Dose-Day-1_250127.pdf

31. Curacel Brings Integrated Insurance to the African Continent, accessed February 12, 2026, https://www.curacel.co/post/curacel-brings-integrated-insurance-to-the-african-continent

32. Leveraging Technology in Africa's Insurance Industry: Opportunities and Challenges, accessed February 12, 2026, https://www.curacel.co/post/leveraging-technology-in-africas-insurance-industry-opportunities-and-challenges

33. Kenya Insurance Solutions - Curacel, accessed February 12, 2026, https://www.curacel.co/kenya-insurance-solutions

34. Top 5 Challenges Facing the Insurance Industry in Africa - Curacel, accessed February 12, 2026, https://www.curacel.co/post/top-5-challenges-facing-the-insurance-industry-in-africa----and-how-ai-is-changing-the-game

35. 5 Ways M-TIBA Kenya Transforms Health Care - The Borgen Project, accessed February 12, 2026, https://borgenproject.org/m-tiba-kenya/

36. A digital mobile health platform increasing efficiency and transparency towards universal health coverage in low- and middle-income countries - PMC, accessed February 12, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9005819/

37. The growth engine for visionary health insurers in Africa, accessed February 12, 2026, https://mtiba.com/

38. The growth engine for visionary health insurers worldwide, accessed February 12, 2026, https://www.carepay.com/

39. Can a mobile health payment platform reshape Kenya's health care system? - Kaiser Permanente International, accessed February 12, 2026, https://international.kaiserpermanente.org/wp-content/uploads/2019/08/Carepay-MTiba_final_080519.pdf

40. Medbook Africa: Digital system keeping medical records accurate - Health Business, accessed February 12, 2026, https://healthbusiness.co.ke/2834/medbook-africa-digital-system-keeping-medical-records-accurate/

41. How Kenya's Medbook is building an end-to-end healthcare ecosystem - - Disrupt Africa, accessed February 12, 2026, https://disruptafrica.com/2020/06/05/how-kenyas-medbook-is-building-an-end-to-end-healthcare-ecosystem/

42. Transforming Supply Logistics for Health Commodity Security in Africa - PMC, accessed February 12, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10906558/

43. Case: Kasha improves women's life quality and health in Africa - Finnfund, accessed February 12, 2026, https://www.finnfund.fi/en/impact/impact-results/impact-stories/case-kasha-improves-womens-life-quality-and-health-africa/

44. A transformative journey: Kasha's mission to provide equal health access to all women, accessed February 12, 2026, https://businessfightspoverty.org/a-transformative-journey-kashas-mission-to-provide-equal-health-access-to-all-women/

45. Making a Bet on Women — Why We Invested in Kasha - Investor X - Webflow Ecommerce website template - Vested World, accessed February 12, 2026, https://www.vestedworld.com/perspectives/making-a-bet-on-women-why-we-invested-in-kasha

46. Plan for Dashboard Mapping Africa's Health Supply Chain - Africa CDC, accessed February 12, 2026, https://africacdc.org/news-item/plan-for-dashboard-mapping-africas-health-supply-chain/

47. Performance vs. Vanity: Metrics That Actually Matter in 2026 | IMS - Creative Ad Agency, accessed February 12, 2026, https://imsolutions.co.za/news/performance-vs-vanity-metrics-that-actually-matter-in-2026/

48. Revenue vs. Vanity: Growth Metrics That Actually Matter - broaderafrica.com, accessed February 12, 2026, https://broaderafrica.com/revenue-vs-vanity-growth-metrics-that-actually-matter-2/

49. A Strategic Guide to Achieving Product-Market Fit for Digital Health Apps in Africa, accessed February 12, 2026, https://medstartups.org/a-strategic-guide-to-achieving-product-market-fit-for-digital-health-apps-in-africa

50. Africa's Health-Tech Beyond EBITDA | by Wasiu Afolabi | Included VC | Dec, 2025 | Medium, accessed February 12, 2026, https://medium.com/included-vc/africas-health-tech-beyond-ebitda-d62cdd3b2b3b

51. Africa HealthTech Growth & Exit Outlook for 2026 - ICON Corporate Finance, accessed February 12, 2026, https://www.iconcorpfin.com/wp-content/uploads/2025/11/Africa_HealthTech_Report.pdf

52. African Tech sees 2,421 layoffs in 2025 profit push - Businessday NG, accessed February 12, 2026, https://businessday.ng/technology/article/african-tech-sees-2421-layoffs-in-2025-profit-push/

53. While healthtech deals rise, healthcare services falls - PitchBook, accessed February 12, 2026, https://pitchbook.com/news/articles/healthtech-pe-deal-activity-eclipses-healthcare-services-as-investors-shifts-priorities

54. Sector Spotlight: The Industries Driving Africa's $1.4B Startup Funding Rebound, accessed February 12, 2026, https://www.axcelafrica.com/en/post/sector-spotlight-the-industries-driving-africa-s-1-4b-startup-funding-rebound